Literature DB >> 33434640

Circular RNAs as biomarkers and therapeutic targets in cancer.

Aferin Beilerli1, Ilgiz Gareev2, Ozal Beylerli3, Guang Yang4, Valentin Pavlov5, Gjumrakch Aliev6, Aamir Ahmad7.   

Abstract

Circular RNAs (circRNAs) are a class of single-stranded closed non-coding RNA molecules (ncRNAs), which are formed as a result of reverse splicing of mRNAs. Despite their relative abundance, an interest in understanding their regulatory importance is rather recent. High stability, abundance and evolutionary conservation among species underline some of their important traits. CircRNAs perform a variety of cellular functions ranging from miRNA and proteins sponges to transcriptional modulation and splicing. Additionally, most circRNAs are expressed aberrantly in pathological conditions suggesting their possible exploitation as diagnostic biomarkers. Their covalent closed cyclic structure resulting in resistance to RNases further makes them suitable as cancer biomarkers. Studies involving human tumors have verified differences in the expression profiles of circRNAs, indicating a regulatory role in cancer pathogenesis and metastasis. As endogenous competitive RNA, circRNAs can regulate tumor proliferation and invasion. Further, some circRNAs located in the nucleus can regulate transcription of genes by binding to RNA polymerase II. In this review, we elaborate the characteristics, functions and mechanisms of action of circRNAs in cancer. We also discuss the possibility of using circRNAs as potential therapeutic targets and biomarkers for cancer.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer biomarkers; Cancer therapeutic targets; Circular RNA; Non-coding RNAs

Mesh:

Substances:

Year:  2021        PMID: 33434640     DOI: 10.1016/j.semcancer.2020.12.026

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  10 in total

1.  Circular RNA circLDLR facilitates cancer progression by altering the miR-30a-3p/SOAT1 axis in colorectal cancer.

Authors:  Ruoqin Wang; Jiayu Wang; Yanjun Chen; Yuqi Chen; Qinhua Xi; Linqing Sun; Xueguang Zhang; Guangbo Zhang; Xianglin Ding; Tongguo Shi; Weichang Chen
Journal:  Cell Death Discov       Date:  2022-07-11

Review 2.  Functions of the bone morphogenetic protein signaling pathway through non-coding RNAs.

Authors:  Ural Mukhametov; Sergey Lyulin; Dmitry Borzunov; Galina Sufianova; Alina Shumadalova; Daming Zhang; Ilgiz Gareev
Journal:  Noncoding RNA Res       Date:  2022-07-09

3.  Upregulated circTMEM59 Inhibits Cell Growth and Metastasis by miR-668-3p/ID4 Axis in Colorectal Cancer.

Authors:  Yifei Feng; Xiaoyuan Wang; Changzhi Huang; Dongsheng Zhang; Tingwei Liu; Chuan Zhang; Yue Zhang; Dongjian Ji; Junwei Tang; Yueming Sun
Journal:  Oxid Med Cell Longev       Date:  2022-05-24       Impact factor: 7.310

Review 4.  Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy.

Authors:  Rongyan Zhao; Jiahui Fu; Lingjuan Zhu; Yi Chen; Bo Liu
Journal:  J Hematol Oncol       Date:  2022-02-05       Impact factor: 17.388

Review 5.  Roles of microRNAs and Long Non-Coding RNAs Encoded by Parasitic Helminths in Human Carcinogenesis.

Authors:  Ana Gabriela Leija-Montoya; Javier González-Ramírez; Gustavo Martínez-Coronilla; María Esther Mejía-León; Mario Isiordia-Espinoza; Fausto Sánchez-Muñoz; Elda Georgina Chávez-Cortez; Viviana Pitones-Rubio; Nicolas Serafín-Higuera
Journal:  Int J Mol Sci       Date:  2022-07-25       Impact factor: 6.208

6.  Circulating ciRS-7 as a potential non-invasive biomarker for epithelial ovarian cancer: An investigative study.

Authors:  Aferin Beilerli; Sema Begliarzade; Albert Sufianov; Tatiana Ilyasova; Yanchao Liang; Ozal Beylerli
Journal:  Noncoding RNA Res       Date:  2022-07-31

Review 7.  The role of long non-coding RNA ANRIL in the development of atherosclerosis.

Authors:  Ilgiz Gareev; Valentin Kudriashov; Albert Sufianov; Sema Begliarzade; Tatiana Ilyasova; Yanchao Liang; Ozal Beylerli
Journal:  Noncoding RNA Res       Date:  2022-09-06

Review 8.  miR-140-5p and miR-140-3p: Key Actors in Aging-Related Diseases?

Authors:  Léa Toury; Diane Frankel; Coraline Airault; Frédérique Magdinier; Patrice Roll; Elise Kaspi
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

9.  Circular RNA: A novel type of biomarker for glioma (Review).

Authors:  Wei Sun; Huandi Zhou; Xuetao Han; Liubing Hou; Xiaoying Xue
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

Review 10.  Circular RNAs' cap-independent translation protein and its roles in carcinomas.

Authors:  Lian He; Changfeng Man; Shouyan Xiang; Lin Yao; Xiaoyan Wang; Yu Fan
Journal:  Mol Cancer       Date:  2021-09-15       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.